Platform
Features
Kurome Therapeutics
Contact
Abram Gordon as an Interim Vice President at CCHMC’s Innovation Ventures, an Executive Director at Cincinnati Children’s Proton Therapy Center and an attorney with 20+ years of legal and management experience in several different industries.
11 members
Facile Therapeutics
Bioculture Group
Lycia Therapeutics
Coya Therapeutics
American Federation for Aging Research (AFAR)